Incidence and US Costs of Corticosteroid-Associated Adverse Events: A Systematic Literature Review

Keyphrases

• Adverse Events 100%
• Corticosteroids 100%
• Systematic Literature Review 100%
• Hypertension 18%
• Patient Demographics 18%
• Peptic Ulcer 18%
• United States 9%
• Dose-response Relationship 9%
• Meta-analysis 9%
• Incidence Rate 9%
• Acute Myocardial Infarction 9%
• Metabolic Syndrome 9%
• Oral Corticosteroids 9%
• Weight Gain 9%
• Systemic Corticosteroids 9%
• Search Terms 9%
• Confounding 9%
• Data Extraction 9%
• Nonfatal Myocardial Infarction 9%
• Literature Search 9%
• Disease Activity 9%
• Systematic Meta-analysis 9%
• Sleep Disturbance 9%
• Patient Costs 9%
• Incidence Risk 9%
• Common Cause 9%
• Underlying Disease 9%
• Risk Ratio 9%
• Lipodystrophy 9%
• Third-party Payers 9%
• Psychiatric Conditions 9%
• Payers 9%
• Retrospective Design 9%
• Cost Analysis 9%
• Pharmacoeconomic Analysis 9%
• Vertebral Fracture 9%
• Review Protocol 9%
• Small number of Studies 9%
• Reporting Item 9%
• Narrative Literature Review 9%
• Publication Type 9%
• Adrenal Suppression 9%
• Gastric Conditions 9%
• Parenteral Corticosteroids 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 100%
• Infection 18%
• Jejunum Ulcer 18%
• Dose-Response Relationship 9%
• Heart Infarction 9%
• Acute Heart Infarction 9%
• Sleep Disorder 9%
• Disease Activity 9%
• Metabolic Syndrome X 9%
• Corticosteroid 9%
• Pharmacoeconomics 9%
• Lipodystrophy 9%
• Spine Fracture 9%